VitaNova Life Sciences Corporation Increase (Decrease) in Deferred Revenue
VitaNova Life Sciences Corporation (VNOV) reported Increase (Decrease) in Deferred Revenue of $0 for the 3-month period ending 2026-07-31, per its 10-Q filed 2026-09-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredRevenue · last filed 2026-09-14
- VitaNova Life Sciences Corporation increase (decrease) in deferred revenue for the quarter ending 2026-07-31 was $0.00, a 100.00% decline year-over-year.
- VitaNova Life Sciences Corporation increase (decrease) in deferred revenue for the quarter ending 2025-10-31 was -$6.49K.
- VitaNova Life Sciences Corporation increase (decrease) in deferred revenue for the quarter ending 2025-07-31 was $10.78K.
- VitaNova Life Sciences Corporation increase (decrease) in deferred revenue for the quarter ending 2024-10-31 was $0.00.
| Period end | Increase (Decrease) in Deferred Revenue 3 month | Increase (Decrease) in Deferred Revenue 6 month |
|---|---|---|
| 2026-07-31 | $0.00 10-Q · filed 2026-09-14 | |
| 2025-10-31 | -$6.49K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-12-15 | $4.29K 10-Q · filed 2025-12-15 |
| 2025-07-31 | $10.78K 10-Q · filed 2026-09-14 | |
| 2024-10-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-12-15 | $0.00 10-Q · filed 2025-12-15 |
| 2024-07-31 | $0.00 10-Q · filed 2025-09-12 |